ACME Capital

Reviewed Updated Mar 30, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location San Francisco, CA
Founded 2018
Fund Size $300M+ (Fund IV + Opportunity Fund, 2022); $1.5B aggregate capital commitments
Stage Focus

Team

Hany Nada Co-Founder and Partner
Scott Stanford Co-Founder and Partner
Alex Fayette Partner
Aike Ho Partner
Christian Tang-Jespersen Partner
Katera Mujadidi Partner, Head of Investor Relations and Fundraising

About

ACME Capital is an early-stage venture firm headquartered in San Francisco that invests in frontier technologies before they reach the mainstream 1. The firm was founded in 2018 by Hany Nada and Scott Stanford, emerging from the rebranding of Sherpa Capital, which Stanford had co-founded with Shervin Pishevar in 2013 2. Following Pishevar’s departure in late 2017, Stanford partnered with Nada, who had previously co-founded GGV Capital in 2000 2.

ACME closed over $300 million for its Fund IV and adjacent Opportunity Fund in February 2022, comprising a $240 million early-stage fund and a $60 million later-stage vehicle 3. This brought the firm’s aggregate capital commitments to $1.5 billion 3. The firm’s previous fund had closed at $181 million 3. ACME invests with a 10-year horizon, with an average time to liquidity of about seven years 4. The firm typically writes checks of $5–10 million and leads approximately 80% of its investments 4.

The founding team brings substantial prior experience: Nada spent over two decades in venture capital at GGV Capital and a decade on Wall Street at Piper Jaffray as a Managing Director and Senior Research Analyst 5. Stanford spent 12 years co-heading Goldman Sachs’s Global Internet Investment Banking, advising on over $80 billion in financings and transactions for companies including Facebook, Google, Airbnb, and Palantir 6. He also co-founded Silicon Foundry, a corporate innovation advisory firm 6.

Over 60% of the firm’s investments in recent years have been into companies with at least one non-male and/or non-white founder, and 68% of ACME’s employees are non-male, non-white, and/or members of the LGBTQ community 1.

Stated Thesis

ACME publicly describes itself as investing in “frontier technologies before they’re mainstream,” backing “deep-tech founders combining technical ambition with decisive execution” 1. The firm states its focus areas include aerospace and defense, physical AI, future of work, digital health, advanced materials, and next-generation manufacturing 1.

Co-founder Hany Nada has described the firm’s approach as being “as off-Broadway as possible,” deliberately avoiding sectors that are currently hot in venture capital to identify what will be hot next 4. Nada emphasizes that customer validation and proof-of-concepts provide sufficient credibility for early-stage investment, and that deep tech companies should only commercialize products that are ready for self-deployment 4.

Scott Stanford has stated that the firm’s sweet spot is “that late seed, Series A” stage, and that “disruptive business models” and “disruptive technology” are at the core of ACME’s interests 7. Stanford has also said the firm requires only two partners to approve an investment: “We need two partners to make a decision. So if two partners are advocating for an investment, the investment will get done” 7.

The firm says it practices what it calls “Impact Value-Add” (IVA), distinguishing its founder support from table-stakes services that venture firms typically deliver 1.

Inferred Thesis

Based on 31 verified portfolio companies from the highlighted portfolio and public sources, ACME’s actual investment behavior shows the following patterns:

Sector Distribution (31 verified investments): - Enterprise Intelligence / Software: 9 of 31 (29%) — Braintrust, BoomPop, Decagon, Forma AI, Laurel, Partiful, Regology, SoLo Funds, Replika - Frontier Health / Digital Health: 7 of 31 (23%) — Tia, Brightside, Canopy, Conceivable, Camber, IonLace, Again - Aerospace & Defense: 4 of 31 (13%) — Astra, Muon Space, True Anomaly, Harmattan AI - Next-Gen Compute (Quantum, Semiconductors): 4 of 31 (13%) — IonQ, Forte, Sphere Semi, Blumind - Consumer: 3 of 31 (10%) — Savage X Fenty, Curio, Avia Games - Industrial Systems: 2 of 31 (6%) — Reshape Bio, Treon, Invert - Other: 2 of 31 (6%) — NIL Technology, Uhnder

Notable patterns: - While ACME emphasizes “deep tech,” a significant portion of the portfolio (29%) is enterprise software / AI-enabled SaaS, which is not typically classified as deep tech. The firm’s actual investing is broader than its stated thesis suggests. - The digital health allocation (23%) is substantial and driven largely by Partner Aike Ho’s focus area. This is consistent with the stated thesis. - Aerospace & defense is a genuine focus area (13%), with investments in multiple space companies (Astra, Muon Space, True Anomaly) and defense AI (Harmattan AI). - The firm has achieved notable public exits: IonQ (NYSE: IONQ), Astra (NASDAQ: ASTR via SPAC in 2021), Cue Health (NASDAQ: HLTH IPO in 2021), and Braintrust (BTRST token) 3. Earlier portfolio companies under the Sherpa Capital umbrella include Uber, Airbnb, Robinhood, Slack, DraftKings, and Opendoor 8.

Stage focus: The firm targets seed through Series B, with a stated sweet spot at late seed / Series A 7. Typical check size is $5–10M 4.

Geographic focus: Primarily US-based companies, with up to 25% allocated to European companies 4. Partner Christian Tang-Jespersen is based in Denmark and focuses on European investments 9.

Co-investor patterns: ACME has co-invested with firms including Accel, Bain Capital Ventures, Menlo Ventures, Eclipse, and Y Combinator across various portfolio companies 1011.

Sample size caveat: This analysis is based on 31 verified investments from ACME’s highlighted portfolio, out of an estimated 127–207 total investments reported by aggregators 812. The actual portfolio is larger and may show different sector distributions.

Portfolio

Company Stage Year Sector Status
IonQ Early Stage ~2019 Quantum Computing IPO (NYSE: IONQ) 3
Astra Early Stage ~2018 Aerospace IPO via SPAC (NASDAQ: ASTR, 2021) 13
Cue Health Series C+ 2020 Diagnostics / Health IPO (NASDAQ: HLTH, 2021) 14
DraftKings Early Stage ~2015 Gaming / Sports IPO (NASDAQ: DKNG) 5
Braintrust Early Stage ~2020 Enterprise / Web3 Public (BTRST) 15
True Anomaly Series C ~2022 Aerospace & Defense Active 10
Muon Space Series B 2024 Aerospace / Satellites Active 16
Conceivable Series A 2025 Digital Health / IVF Active 17
Canopy Early Stage 2025 Healthcare Safety Active 17
Tia Series A/B ~2020 Women’s Health Active 18
Decagon Series B ~2024 AI / Customer Support Active 11
Partiful Series A ~2023 Consumer / Events Active 11
Savage X Fenty Growth ~2020 Consumer / Fashion Active 11
Reshape Bio Series A 2024 Lab Automation / Biotech Active 19
Forma AI Early Stage ~2021 Enterprise / Sales Comp Active 15
Replika Early Stage ~2019 AI / Consumer Active 15
Sphere Semi Seed ~2023 Semiconductors Active 15
Harmattan AI Early Stage ~2023 Defense / AI Active 15
Curio Seed ~2024 Consumer / EdTech Active 15
Brightside Early Stage ~2020 Digital Health / Mental Health Active 20
SoLo Funds Early Stage ~2020 Fintech / Lending Active 15
Laurel Early Stage ~2021 Enterprise / AI Active 15
Regology Early Stage ~2021 Enterprise / RegTech Active 15
BoomPop Early Stage ~2021 Enterprise / Events Active 15
Avia Games Early Stage ~2020 Gaming Active 15
Blumind Seed ~2022 Semiconductors / AI Active 15
NIL Technology Growth ~2022 Optics / Hardware Active 15
Treon Early Stage ~2022 Industrial IoT Active 15
Again Series A 2024 Green Chemistry / Climate Active 15
Invert Early Stage ~2023 Bioprocessing / Software Active 15
IonLace Early Stage ~2023 Proteomics / AI Active 15
Camber Early Stage ~2023 Healthcare Billing / AI Active 15
Uhnder Early Stage ~2019 Autonomous Vehicles / Radar Active 4
Arya Early Stage ~2024 Healthcare AI Active 15
Stendr Pre-Seed 2026 Defense Tech / Drones Active 21

Note: This table represents approximately 35 of an estimated 127–207 total investments. Many investments, particularly those made under the Sherpa Capital name (Uber, Airbnb, Robinhood, Slack, Opendoor, Rent the Runway, Wag), are not included as they predate the ACME Capital branding. Years marked with ~ are approximations based on available data.

In Their Own Words

Hany Nada on their contrarian approach: “If there’s a sector that’s hot in VC we tend to shy away from it and look for whatever is going to be hot next. When we look at our investments in quantum computing and semiconductor chips, they were done way before other VCs got interested in those topics.” — Hello Tomorrow interview 4

Hany Nada on founder-market fit: “Alignment of passion + product + market of an entrepreneur = Gold.” — Hello Tomorrow interview 4

Hany Nada on early-stage conviction: “If you come to me and say ‘Listen, I have my prototype in a customer’s hands, the customer likes it, there are some things that we need to continue to work on, but I believe this initial indication from customers gives us credibility and confidence that this is the right go-to-market strategy and product’ — that’s enough for me as an early stage investor to invest in.” — Hello Tomorrow interview 4

Scott Stanford on risk calibration: “We are early stage investors and by definition, we are taking more risk than a growth investor. However, we’ve been through this, our 10th fund, if you look at it collectively between Hany and my experience, we found this kind of place, this calibration point where we’re not investing in science projects.” — LA Venture Podcast 7

Scott Stanford on decision speed: “We need two partners to make a decision. So if two partners are advocating for an investment, the investment will get done.” and “We could have a term sheet out in the night if we needed to.” — LA Venture Podcast 7

Scott Stanford on disruption: “Everything we look for kind of has disruption at the core. We thrive on disruptive business models.” — LA Venture Podcast 7

Aike Ho on digital health venture outlook: “It’s going to be a world of hurt for the next couple of years.” and “The reality is that healthcare, unlike many industries in this country, has its own laws of physics of how things work.” — Fortune Brainstorm Health, April 2023 20

What Founders Say

Carolyn Witte, Co-founder and CEO, Tia: “The ACME team, especially Aike, has been a friend of Tia, following our company closely and always there to offer helpful counsel.” She added: “I work closely with Aike and Scott Stanford on strategic partnerships. I have particularly benefited from Aike and Stanford’s willingness to roll up their sleeves and help us navigate complex business decisions.” — Crunchbase blog interview 18

Jonathan Dyer, CEO, Muon Space: Dyer has credited ACME with providing operational support beyond capital, including regulatory guidance and customer connections 1.

No additional independently sourced founder testimonials found beyond the firm’s own website testimonials.

Sources


  1. ACME Capital website, homepage, accessed March 2026. https://www.acme.vc/

  2. Golden wiki, “ACME Capital,” accessed March 2026. https://golden.com/wiki/ACME_Capital-ZXY5ANE

  3. TechCrunch, “ACME Capital, run by Scott Stanford and Hany Nada, has $300 million more to invest in early startups,” February 2022, accessed March 2026. https://techcrunch.com/2022/02/04/acme-capital-run-by-scott-stanford-and-hany-nada-has-300-million-more-to-invest-in-early-startups/

  4. Hello Tomorrow, “Discover ACME | With Hany Nada, Co-founder & Partner,” accessed March 2026. https://hello-tomorrow.org/discover-acme-with-hany-nada-co-founder-partner/

  5. ACME Capital website, “Hany Nada” bio page, accessed March 2026. https://www.acme.vc/people/hany-nada/

  6. ACME Capital website, “Scott Stanford” bio page, accessed March 2026. https://www.acme.vc/people/scott-stanford/

  7. LA Venture Podcast (Ten One Ten / dot.la), “Scott Stanford — ACME,” accessed March 2026. https://www.tenoneten.com/podcast/scott-stanford-acme

  8. Tracxn, “ACME — 2025 Investor Profile, Portfolio, Team & Investment Trends,” accessed March 2026. https://tracxn.com/d/venture-capital/acme/__ZmdScNi4Bd56fcVNW0fFWhaF6YMA68OwZ4Ido575Rh8

  9. Crunchbase, “Christian Tang Jespersen — Partner @ ACME Capital,” accessed March 2026. https://www.crunchbase.com/person/christian-tang-jespersen

  10. SpaceNews, “True Anomaly raises $100 million to expand investments in space security technologies,” accessed March 2026. https://spacenews.com/true-anomaly-raises-100-million-to-expand-investments-in-space-security-technologies/

  11. Decagon, “Decagon raises $65m Series B led by Bain Capital Ventures,” accessed March 2026. https://decagon.ai/resources/series-b

  12. Crunchbase, “ACME Capital — Company Profile & Funding,” accessed March 2026. https://www.crunchbase.com/organization/acme-capital

  13. CNBC, “Rocket builder Astra to go public via SPAC at $2.1 billion valuation,” February 2021, accessed March 2026. https://www.cnbc.com/2021/02/02/rocket-startup-astra-to-go-public-astr-via-spac-at-2point1b-valuation.html

  14. MedCity News, “Portable diagnostics company Cue raises $200M in IPO,” September 2021, accessed March 2026. https://medcitynews.com/2021/09/portable-diagnostics-company-cue-raises-200m-in-ipo/

  15. ACME Capital website, “Highlighted Portfolio,” accessed March 2026. https://www.acme.vc/highlighted-portfolio

  16. Muon Space, “Muon Space Secures $56M Series B Funding,” accessed March 2026. https://www.muonspace.com/press/muon-space-secures-56m-series-b-funding-surpasses-100m-in-customer-contracts-in-2024-including-landmark-agreement-with-snc

  17. Tracxn, “ACME — Top portfolio companies,” accessed March 2026. https://tracxn.com/d/venture-capital/acme/__ZmdScNi4Bd56fcVNW0fFWhaF6YMA68OwZ4Ido575Rh8/portfolio

  18. Crunchbase blog, “Female Founded + Funded: A Conversation with ACME Capital and Tia,” accessed March 2026. https://about.crunchbase.com/blog/female-founded-funded-a-conversation-with-acme-capital-and-tia

  19. BusinessWire, “Reshape Bio Raises $8 Million to Automate Experimental Tasks,” February 2023, accessed March 2026. https://www.businesswire.com/news/home/20230209005125/en/Reshape-Bio-Raises-$8-Million-to-Automate-Experimental-Tasks-and-Build-New-Infrastructure-for-Food-Agriculture-and-Microbial-Research

  20. Fortune, “Venture capital is in for a ‘world of hurt,’ says investor,” April 2023, accessed March 2026. https://fortune.com/2023/04/26/venture-capital-digital-healthcare-world-of-hurt-aike-ho-acme-fortune-brainstorm-health/

  21. The Next Web, “Norwegian defence startup Stendr raises $5.4M,” April 2026. https://thenextweb.com/news/stendr-5-4m-pre-seed-ai-counter-drone-defence